Clinical Trials

Clinical trials are research studies in which people help doctors find ways to improve health and cancer care. Each study tries to answer scientific questions and to find better ways to prevent, diagnose, or treat cancer. We provide you access to a wide variety of clinical trials and continue to open new trials as they become available. We are committed to providing innovative treatments at our community clinics.

 

IRB 10489 (OPEN)
Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer (The "METRIC" Study)

IRB 11260 (OPEN)
MK-3475 KEYNOTE 052 (Pembrolizumab) - MK-3475-052: A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced/Unresectable or Metastatic Urothelial Cancer who are ineligible for Cisplatin based Chemotherapy

IRB 10866 (OPEN)
ABI-007-NCL-005: Safety and Efficacy of nab-Paclitaxel (Abraxane) in Combination with Carboplatin as First Line Treatment in Elderly Subjects with Advanced Non-Small Cell Lung Cancer(NSCLC): A Phase IV, Randomized, Open-Label, Multi-center Study

IRB 11213 (OPEN)
Prospective Observational Study of Patients with Polycythemia Vera is US Clinical Practices- REVEAL

IRB 10540 (OPEN)
A Phase 2, Multicenter, Open-Label, Randomized Study of nab-Paclitaxel Plus Gemcitabine Alone as Adjuvant Therapy in Subjects with Surgically Resected Pancreative Adenocarcinoma (Apact)

IRB 10768 (OPEN)
A Randomized, Double-Blind, Phase 3 Study of the JAK 1/2 Inhibitor, Ruxolitnib, or Placebo in Combination with Capecitabine in Subjects with Advanced or Metastatic Adenocarcinoma of the Pancreas Who Have Failed or Are Intolerant to First-Line Chemotherapy